Oct 13, 2026 · 1h 20m
Longevity medicine turns influence into a medical liability
Part One: Peter Attia and the Cult of Longevity
The episode asks whether elite preventive care can expand health while weakening medical humility and widening access gaps.
- 1Longevity medicine prioritizes extending healthy, independent years rather than simply maximizing lifespan.
- 2Concierge care makes personalized prevention more available to wealthy patients while reinforcing unequal access to medicine.
- 3Attia’s gentamicin experiment exposes why supervision, standardized training, and humility matter when innovation meets patient safety.
Don't miss
The hosts dissect Attia’s account of changing a patient’s gentamicin dosing protocol and explain why the experiment crossed essential safety boundaries.
The brief
Robert and Dr. Kaveh Hoda examine Peter Attia’s rise as a longevity physician whose credibility reaches across biohacking, fitness, technology, and manosphere communities.
The episode separates health span from mere lifespan, then asks whether concierge longevity care turns prevention into a subscription privilege for wealthy patients.
Attia’s departure from surgical residency becomes a test of his belief that conventional training suppresses exceptional thinkers—and of what that belief overlooks.
The standout case is Attia’s gentamicin experiment: a dosing change that shows why narrow therapeutic windows make unauthorized innovation dangerous, however intelligent the motive.
The first part ends as Attia leaves residency for consulting, with the larger question unresolved: can medical influence outpace medical humility?